Literature DB >> 3311209

Mixed blood chimerism in T cell-depleted bone marrow transplant recipients: evaluation using DNA polymorphisms.

S Bretagne1, M Vidaud, M Kuentz, C Cordonnier, T Henni, G Vinci, M Goossens, J P Vernant.   

Abstract

We have used DNA sequence polymorphism analysis to document engraftment after T cell-depleted bone marrow transplantation (BMT), with a selected panel of four DNA probes. In contrast to nondepleted BMT recipients, the patients who received T cell-depleted marrow exhibited a mixed blood chimerism. This mosaicism was observed before graft failure or relapse in six patients. However, in five other patients, this mixed chimerism was not followed by these complications with a follow-up of 9 to 31 months after transplantation. Our results support the hypothesis that transplanted bone marrow T cells may help to maintain engraftment by eliminating host cells that can cause graft failure.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3311209

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  6 in total

1.  Quantitative evaluation of post-bone marrow transplant engraftment status using fluorescent-labeled variable number of tandem repeats.

Authors:  R A Luhm; D B Bellissimo; A J Uzgiris; W R Drobyski; M J Hessner
Journal:  Mol Diagn       Date:  2000-06

2.  Eradication of leukaemic marrow and prevention of leukaemia relapse with total body irradiation and bone marrow transplantation.

Authors:  F Frassoni
Journal:  Med Oncol Tumor Pharmacother       Date:  1991

3.  Effects of mixed chimerism and immune modulation on GVHD, disease recurrence and survival after HLA-identical marrow transplantation for hematologic malignancies.

Authors:  S J Park; W S Min; I H Yang; H J Kim; C K Min; H S Eom; D W Kim; C W Han; J W Lee; C C Kim
Journal:  Korean J Intern Med       Date:  2000-12       Impact factor: 2.884

4.  Possible role of minor h antigens in the persistence of donor chimerism after stem cell transplantation; relevance for sustained leukemia remission.

Authors:  Cornelis R van der Torren; Yvette van Hensbergen; Susanne Luther; Zohara Aghai; Zuzana Stachová Rychnavská; Manon Slot; Sicco Scherjon; Nicolaus Kröger; Arnold Ganser; Eva M Weissinger; Els Goulmy; Lothar Hambach
Journal:  PLoS One       Date:  2015-03-16       Impact factor: 3.240

5.  Donor CD8 cells prevent allogeneic marrow graft rejection in mice: potential implications for marrow transplantation in humans.

Authors:  P J Martin
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

6.  Very Long Term Stability of Mixed Chimerism after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Hematologic Malignancies.

Authors:  Emmanuel Levrat; Eddy Roosnek; Stavroula Masouridi; Bilal Mohty; Marc Ansari; Jean Villard; Jakob R Passweg; Yves Chalandon
Journal:  Bone Marrow Res       Date:  2015-11-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.